HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remote Ischemic Post-Conditioning Therapy is Protective in Mouse Model of Traumatic Optic Neuropathy.

Abstract
Traumatic optic neuropathy (TON) is characterized by visual dysfunction after indirect or direct injury to the optic nerve following blunt head trauma. TON is associated with increased oxidative stress and inflammation resulting in retinal ganglion cell (RGC) death. Remote ischemic post-conditioning (RIC) has been shown to enhance endogenous protective mechanisms in diverse disease models including stroke, vascular cognitive impairment (VCI), retinal injury and optic nerve injury. However, the protective mechanisms underlying the improvement of retinal function and RGC survival after RIC treatment remain unclear. Here, we hypothesized that RIC therapy may be protective following TON by preventing RGC death, oxidative insult and inflammation in the mouse retina. To carry out the study, mice were divided in three different groups (Control, TON and TON + RIC). We harvested retinal tissue 5 days after TON induction for western blotting and histochemical analysis. We observed increased TON-induced retinal cell death compared with controls by cleaved caspase-3 immunohistochemistry. Furthermore, the TON cohort demonstrated increased TUNEL positive cells which were significantly attenuated by RIC. Immunofluorescence data showed that oxidative stress markers dihydroethidium (DHE), NOX-2 and nitrotyrosine expression were elevated in the TON group relative to controls and RIC therapy significantly reduced the expression level of these markers. Next, we found that the proinflammatory cytokine TNF-α was increased and anti-inflammatory IL-10 was decreased in plasma of TON animals, and RIC therapy reversed this expression level. Interestingly, western blotting of retinal tissue showed that RGC marker Brn3a and tight junction proteins (ZO-1 and Occludin), and AMPKα1 expression were downregulated in the TON group compared to controls. However, RIC significantly increased the expression levels of these proteins. Together these data suggest that RIC therapy activates endogenous protective mechanisms which may attenuate TON-induced oxidative stress and inflammation, and improves BRB integrity.
AuthorsMuhammad Nadeem, Adam Kindelin, Laura Mahady, Kanchan Bhatia, Md Nasrul Hoda, Andrew F Ducruet, Saif Ahmad
JournalNeuromolecular medicine (Neuromolecular Med) Vol. 23 Issue 3 Pg. 371-382 (09 2021) ISSN: 1559-1174 [Electronic] United States
PMID33185833 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020. Springer Science+Business Media, LLC, part of Springer Nature.
Chemical References
  • Eye Proteins
  • IL10 protein, mouse
  • Pou4f1 protein, mouse
  • Transcription Factor Brn-3A
  • Tumor Necrosis Factor-alpha
  • Superoxides
  • Interleukin-10
  • 3-nitrotyrosine
  • Tyrosine
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • Adenylate Kinase
  • Casp3 protein, mouse
  • Caspase 3
Topics
  • Adenylate Kinase (biosynthesis, genetics)
  • Animals
  • Blood-Retinal Barrier
  • Caspase 3 (biosynthesis, genetics)
  • Cell Death
  • Eye Proteins (biosynthesis, genetics)
  • Hindlimb (blood supply)
  • Interleukin-10 (blood)
  • Ischemia (physiopathology)
  • Ischemic Postconditioning
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia (physiology)
  • Models, Animal
  • NADPH Oxidase 2 (analysis)
  • Neuroinflammatory Diseases (etiology, prevention & control)
  • Optic Nerve Injuries (therapy)
  • Oxidative Stress
  • Retinal Ganglion Cells (pathology)
  • Superoxides (analysis)
  • Transcription Factor Brn-3A (biosynthesis, genetics)
  • Tumor Necrosis Factor-alpha (blood)
  • Tyrosine (analogs & derivatives, analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: